GlassScriptPhysician profile
Natalie Akerman
NPI 1366723140
$8,342.04
in general payments reported to CMS, 2019-2025
33 companies · $2,411 in 2025
The $2,411 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $531 · 2022: $1,510 · 2023: $2,224 · 2024: $1,667 · 2025: $2,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,143 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,142.59 |
| Education | $158.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,247.52 | 2021-2025 | Evenity, Prolia, Enbrel |
| Ani Pharmaceuticals, INC. | $1,040.93 | 2022-2025 | Purified Cortrophin Gel |
| Abbvie INC. | $862.28 | 2021-2025 | Skyrizi, Rinvoq, Humira |
| Ucb, INC. | $794.48 | 2021-2025 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $595.49 | 2021-2025 | Tremfya, Simponi Aria |
| Glaxosmithkline, LLC. | $444.11 | 2021-2025 | Benlysta, Nucala |
| Mallinckrodt Hospital Products INC. | $441.58 | 2021-2025 | Acthar |
| Horizon Therapeutics Plc | $428.26 | 2021-2023 | Krystexxa, Uplizna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $419.39 | 2022-2025 | Ofev, Cyltezo |
| Pfizer INC. | $252.84 | 2022-2025 | |
| Novo Nordisk INC | $206.83 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $191.26 | 2024-2025 | Orencia |
| Astrazeneca Pharmaceuticals LP | $153.81 | 2022-2025 | Saphnelo |
| Janssen Scientific Affairs, LLC | $152.67 | 2021-2022 | |
| Fresenius Kabi USA, LLC | $141.61 | 2023-2024 | Idacio |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $131.63 | 2022-2024 | Taltz |
| Organon LLC | $128.24 | 2022-2025 | Renflexis, Hadlima |
| Radius Health, INC. | $98.99 | 2023-2025 | Tymlos |
| Alvogen INC | $94.24 | 2023-2025 | Teriparatide |
| Novartis Pharmaceuticals Corporation | $80.75 | 2023-2025 | |
| Depuy Synthes Sales INC. | $77.49 | 2023-2024 | Orthovisc |
| Kiniksa Pharmaceuticals International, Plc | $62.73 | 2024 | Arcalyst |
| Alexion Pharmaceuticals, INC. | $60.17 | 2023-2024 | Strensiq |
| Sobi, INC | $37.29 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.13 | 2023 | Hyqvia |
| Teva Pharmaceuticals USA, INC. | $28.84 | 2024 | Truxima |
| Kiniksa Pharmaceuticals, LTD. | $27.67 | 2023 | Arcalyst |
| Ultragenyx Pharmaceutical INC. | $21.99 | 2023 | Crysvita |
| Mylan Institutional INC. | $20.66 | 2023 | Hulio |
| Scilex Pharmaceuticals INC. | $18.37 | 2024 | |
| Aurinia Pharma U.S., INC. | $18.05 | 2022 | |
| Genentech USA, INC. | $16.01 | 2023 | Actemra |
| Sandoz INC. | $15.73 | 2023 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Akerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.